ANLON HEALTHCARE L...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO ANLON HEALTHCARE L...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Anlon Healthcare Ltd.

Anlon Healthcare Ltd.

NSE & BSE · Mainboard IPO
Listed NSE & BSE Mainboard Live Chart
Issue Price
₹91
₹91
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹91
Based on GMP
Min. Investment
₹14,924
1 lot × 164 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
26 Aug 2025
Close Date
29 Aug 2025
Allotment
01 Sep 2025
Listing Date
03 Sep 2025
Exchange
NSE & BSE
Price Band
₹91
Listing Price
See chart
Allotment Status
Price Band
₹91
Per share
Face Value
₹10 per share
 
Lot Size
164 Shares
per lot
Issue Size
1,33,00,000 shares (aggregating up to ₹121.03 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹14,924
1 lot
Pre-IPO Holding
3,98,51,500 shares
Promoters
Post-IPO Holding
5,31,51,500 shares
Promoters
P/E (Pre)
17.67x
 
P/E (Post)
23.57x
 
EPS (Pre)
₹5.15
 
EPS (Post)
₹3.86
 
UPI Deadline
2025-08-29
Mandate
Anchor AllotmentMon, 25 Aug 2025
Basis of AllotmentMon, 01 Sep 2025
Refund InitiationTue, 02 Sep 2025
Demat CreditTue, 02 Sep 2025
Listing DayWed, 03 Sep 2025
UPI Mandate Deadline2025-08-29
Sale TypeFresh Capital
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Anlon Healthcare Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 29 Aug 2025.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
13,300,000
100% ₹121.03
IPO Shares Offered
Anlon Healthcare Ltd. IPO total issue size: ₹121.03 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Total 13,300,000 ₹121.03
100.00%
* Based on upper price band ₹91 per share
Lot Size & Investment
Lot Size
164
Shares per Lot
Issue Price
₹91.00
Upper Band
Min Investment
₹14,924
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)2328₹29,848
Retail (Max — 13 Lots)132,132₹194,012
S-HNI (Min — 14 Lots)142,296₹208,936
B-HNI (Min — 68 Lots)6811,152₹1,014,832
* Issue Price ₹91 × Lot Size 164 shares
IPO Schedule
Anchor
25 Aug 2025
✓ Done
IPO Open
26 Aug 2025
✓ Done
IPO Close
29 Aug 2025
✓ Done
Allotment
01 Sep 2025
✓ Done
Refunds
02 Sep 2025
✓ Done
Demat Credit
02 Sep 2025
✓ Done
Listing Day
03 Sep 2025
✓ Done
Anlon Healthcare Ltd. — Live Price LIVE
₹91.00
INR · BSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹91.00 Live Price
About Anlon Healthcare Ltd.
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).The company manufactures high-purity pharmaceutical intermediates (for API production) and active pharmaceutical ingredients (used in formulations for medicines, nutraceuticals, personal care, and animal health products).The company offers pharmaceutical intermediates, APIs for medicines, nutraceuticals, personal care, and veterinary products, all manufactured following Indian and international pharmacopeia standards like IP, BP, EP, JP, and USP.In addition to manufacturing Pharma Intermediates and APIs to global standards, the company now offers custom manufacturing for complex chemicals, exceeding purity standards and reducing impurities to meet specific customer needs.The company has received Drug Master File (DMF) approval from ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs. The company has filed 21 DMFs with global authorities and is in the process of filing for Ketoprofen and Dexketoprofen Trometamol approvals.The company ensures product quality through rigorous testing, analysis, and process improvements. Supported by four labs, the 34-member team, including 24 science graduates, ensures products meet customer and industry standards.The company's product portfolio consists of sixty-five (65) commercialised products and twenty-eight (28) products at pilot stage and forty-nine (49) products at laboratory testing stage/ laboratory scale stage.Products:Pharma Intermediates:Cyanoethylbe nzoic acid, Ketonitrile and Methyldeslor atadine, these serve as a key starting material or as an advance intermediate for manufacturing of APIs.Active Pharmaceutical Ingredients: The company’s APIs are key components in pharmaceutical products, delivering therapeutic effects. They are used in formulations like tablets, capsules, ointments, syrups, and in nutraceuticals, personal care, and veterinary products.Competitive Strengths:Strong product portfolio and scalable business.Strong Promoters and Experienced Management Team.High entry and exit barriers due to long customer approval cycles and strict product standards.In-house Testing, Quality Control and Quality Assurance for quality control.Focus on Quality, Environment, Health and Safety.
Objects of the Issue
1
1 Funding capital expenditure requirements for Proposed Expansion
2
2 Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company
3
3 Funding the working capital requirements of the Company
4
4 General corporate purposes
Anlon Healthcare Ltd. Financials (Amount in Crore)
Revenue from Operations
₹113.1
31 Mar 2023
₹66.7
31 Mar 2024
₹120.5
31 Mar 2025
Profit After Tax (PAT)
₹5.8
31 Mar 2023
₹9.7
31 Mar 2024
₹20.5
31 Mar 2025
Particulars31 Mar 202531 Mar 202431 Mar 2023
Revenue from Operations 120.46 66.69 113.12
EBITDA 32.38 15.57 12.66
Profit After Tax (PAT) 20.52 9.66 5.82
Net Worth 80.42 21.03 7.37
Total Assets 181.30 128.00 111.55
Reserves & Surplus 40.57 5.03 -4.63
Borrowings 58.35 74.56 66.39
EBITDA Margin (%) 26.88%
PAT Margin (%) 17.06%
P/BV Ratio
4.51
RoE
40.45%
RoCE
21.93%
RoNW
25.51%
PAT Margin
17.06%
EBITDA Margin
26.88%
Debt/Equity
0.73
Issue Structure & Shareholding
Total Shares Offered1,33,00,000 (100.00%)
Net Offer to PublicN/A
Reserved for Market MakerN/A
Pre-Issue Promoter Holding3,98,51,500 shares
Post-Issue Promoter Holding5,31,51,500 shares
P/BV Ratio4.51
RoE40.45%
RoCE21.93%
Debt / Equity0.73
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Interactive Financial Services Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Anlon Healthcare Ltd. IPO subscribed?

Anlon Healthcare Ltd. IPO is subscribed 1.00 times by Aug 29, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Anlon Healthcare Ltd. IPO retail subscription status?

The Anlon Healthcare Ltd. IPO retail category is subscribed 1.00 times as of 29 Aug 2025. The retail portion is oversubscribed.

How to subscribe Anlon Healthcare Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 26 Aug 2025 and closes 29 Aug 2025. Min investment: ₹14,924 (1 lot = 164 shares). UPI mandate: 2025-08-29.

How many times Anlon Healthcare Ltd. IPO subscribed?

The Anlon Healthcare Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Anlon Healthcare Ltd. IPO allotment?

Check allotment on the registrar website (Kfin Technologies Ltd.) at https://ipostatus.kfintech.com/. Enter your PAN, application number or DP/Client ID. Allotment date: 01 Sep 2025. Refunds: on 02 Sep 2025.

When Anlon Healthcare Ltd. IPO will be listed?

The Anlon Healthcare Ltd. IPO listing date is 03 Sep 2025, Wednesday. Listed on: NSE & BSE. Issue price: ₹91. Estimated listing: ₹91. GMP: NIL.

When Anlon Healthcare Ltd. IPO close?

The Anlon Healthcare Ltd. IPO closes on 29 Aug 2025, Friday. UPI mandate: 2025-08-29. Allotment: 01 Sep 2025. Listing: 03 Sep 2025.